000 01474 a2200445 4500
005 20250516220005.0
264 0 _c20140925
008 201409s 0 0 fre d
022 _a0040-5957
024 7 _a10.2515/therapie/2013076
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPochard, Liselotte
245 0 0 _a[Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)].
_h[electronic resource]
260 _bTherapie
_c
300 _a149-55 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAdverse Drug Reaction Reporting Systems
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Retroviral Agents
_xadverse effects
650 0 4 _aDatabases, Factual
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xepidemiology
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPharmacovigilance
650 0 4 _aPrevalence
650 0 4 _aSoftware
700 1 _aHauviller, Laurent
700 1 _aCuzin, Lise
700 1 _aEyvrard, Fréderic
700 1 _aSommet, Agnès
700 1 _aMontastruc, Jean-Louis
700 1 _aBagheri, Haleh
773 0 _tTherapie
_gvol. 69
_gno. 2
_gp. 149-55
856 4 0 _uhttps://doi.org/10.2515/therapie/2013076
_zAvailable from publisher's website
999 _c23916142
_d23916142